TCL Archive Also NIH unveils Roadmap initiatives, releases four RFAs; Director Zerhouni defends peer review before House, Senate oversight committees, seeks greater authority for trans-NIH initiatives. October 3, 2003
TCL Archive ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic. April 9, 2010
TCL Archive DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial February 1, 1985